Melbourne Clinical Trials
The Type 2 Diabetes Study
The study drug is a potential new treatment for Type 2 Diabetes (T2D), which prevents the body from maintaining healthy levels of glucose in the blood.
4 nights
visits
T2D is a complex condition that can affect the entire body. Part 2 of the study focuses on how the drug is metabolised in the body of participants who currently have Type 2 Diabetes.
The study drug is a powder that is taken orally after being mixed with a solution. The drug is designed to activate an enzyme that could reduce the complications caused by T2D. In this study, the powder form of the drug will be compared to a capsule form, in order to see whether the capsule is as effective as the powder.
Eligibility
Biological Sex and Medical History Males diagnosed with Type 2 Diabetes at least 6 months ago
Age 18-55 years old
BMI 18-40 kg/m²
Medication Medications to treat Type 2 Diabetes are permitted (not insulin)
Smoking History Non-smokers and casual smokers only (less than 5 cigarettes/week)